+1 (704) 266-3234

MediPoint: Prosthetic Heart Valves - Current And Future Players

Published on: Feb 2015 | From USD $3500 | Published By: GLOBAL DATA | Number Of Pages:

MediPoint: Prosthetic Heart Valves - Current and Future Players


The global prosthetic heart valves (PHV) market is a dynamic, billion-dollar market that is saturated with numerous players developing innovative technologies. Recent advancements in the field of interventional cardiology have greatly expanded the potential of therapeutic applications. Prosthetic heart valves, including mechanical valves, tissue valves, and transcatheter valves, can be used to treat patients with valvular heart disease affecting the aortic or mitral valves. They can be delivered either via open-heart surgery or transcatheter aortic valve implantation (TAVR).

The rising prevalence of disease and associated risk factors, an aging population, and improved clinical outcomes with minimally invasive techniques are expected to drive the growth of the global prosthetic heart valve market. Emerging technologies such as repositionable and retrievable transcatheter aortic valves will optimize clinical outcomes for patients. With improvements in the design of transcatheter valves, they have the potential to become the standard of treatment for valvular heart disease in the future.

The report provides up-to-date information and in-depth analysis on the key players that shape this market. This includes an analysis of company market shares, industry trends, and corporate strategy. This report is built using data and information sourced from secondary sources and primary research interviews with leading Interventional Cardiologists, with in-house analysis conducted by GlobalData’s team of industry experts.

*This is an on-demand report and will be delivered within 4 working days (excluding weekends) of the purchase.


Key Benefits

“What Physicians Think” quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. In this report you will understand the perceptions of leading Interventional Cardiologists and Cardiac Surgeons from around the world. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.


- Investigation of current and future market competition for prosthetic heart valves.
- Competitive Assessment including device approval analysis.
- Coverage of key market players and company profiles including business description, financial overview, product portfolio assessment, and SWOT analysis.
- Strategic Assessment of the market through market impact analysis, future market scenario, and company analysis.

Reasons to buy

- Gain a high level view of the trends shaping and driving the PHV market.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Drive revenues, formulate effective sales and marketing strategies, and gain in-depth understanding of the competitive landscape.
- Take a comprehensive look at the market’s device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market.

1 Table of Contents
1.1 List of Tables
2 Introduction
2.1 Anatomy
2.2 Epidemiology
2.3 Related Reports
3 Competitive Assessment
3.1 Overview
3.2 Classification Based on Features
3.2.1 Mechanical Heart Valves
3.2.2 Tissue Heart Valves
3.2.3 Transcatheter Heart Valves
3.3 Market Dynamics Analysis
3.4 Product Profiles
3.4.1 Mechanical Heart Valves
3.4.2 Tissue Heart Valves
3.4.3 Transcatheter Heart Valves
4 Pipeline Assessment
4.1 Overview
4.2 Product Profiles
4.2.1 Cytograft Tissue Valve (Cytograft Tissue Engineering)
4.2.2 Centera Valve (Edwards Lifesciences)
4.2.3 Colibri Heart Valve (Colibri Heart Valve)
4.2.4 Cormove (Perouse Medical)
4.2.5 Endovalve (Micro Interventional Devices)
4.2.6 HLT Transcatheter Valve System (Heart Leaflet Technology)
4.2.7 Inovare Valve (Braile Biomédica)
4.2.8 Kalangos Valve (Leman Cardiovascular)
4.2.9 Tiara Valve (Neovasc)
4.2.10 Trinity Valve (Transcatheter Technologies GmbH)
4.2.11 Vanguard Exchangeable Heart Valve System (ValveXchange)
5 Current and Future Players
5.1 Overview
5.2 Trends in Corporate Strategy
5.3 Company Profiles
5.3.1 AorTech International
5.3.2 Boston Scientific
5.3.3 Braile Biomédica
5.3.4 CardiAQ Valve Technologies
5.3.5 Claret Medical
5.3.6 Colibri Heart Valve
5.3.7 Cytograft Tissue Engineering
5.3.8 Direct Flow Medical
5.3.9 Edwards Lifesciences
5.3.10 Heart Leaflet Technologies
5.3.11 JenaValve Technology
5.3.12 Leman Cardiovascular
5.3.13 Micro Interventional Devices
5.3.14 Neovasc
5.3.15 On-X Life Technologies, Inc.
5.3.16 Perouse Medical
5.3.17 Sorin Group
5.3.18 St. Jude Medical
5.3.19 Symetis
5.3.20 Transcatheter Technologies GmbH
5.3.21 TTK Healthcare
5.3.22 ValveXchange
6 Appendix
6.1 Bibliography
6.2 Abbreviations
6.3 Report Methodology
6.3.1 Overview
6.3.2 Coverage
6.3.3 Secondary Research
6.4 Forecasting Methodology
6.5 Physicians and Specialists Included in This Study
6.6 About the Authors
6.6.1 Analysts
6.6.2 Global Head of Healthcare
6.7 About GlobalData
6.8 Disclaimer

Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

The market engineered data is verified and validated by a number of experts, both in-house and external.

After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $3500
USD $5385
USD $8300

Why Us

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.